Medicare Part D Insulin Savings

Calculator and checkbook image

The Centers for Medicare & Medicaid Services (CMS) have developed the Part D Senior Savings Model for the 2021 plan year, which may lower the copay for eligible Medicare beneficiaries seeking insulin.

The Part D Senior Savings Model allows and encourages participating Part D enhanced alternative plans to offer a decreased out-of-pocket cost, with a maximum of $35 for the copay of a month’s supply of a broad range of insulins.

Because one in every three Medicare beneficiaries has diabetes, the Part D Senior Savings Model can make a difference for many Americans. Rather than be expected to pay 25% of the drug’s cost in the coverage gap, Medicare beneficiaries can now pay a predictable and manageable copay of up to $35.

Based on estimations made by CMS, beneficiaries with a participating plan who use insulin could see an average out-of-pocket savings of $446, or 66%. The Part D Senior Savings Model applies to multiple kinds of insulin, in both pen and vial dosage forms for rapid-acting, short-acting, intermediate-acting, and long-acting insulins.

Increased insulin access may help reduce severe medical issues associated with untreated diabetes, like vision loss, kidney failure, and heart attacks. For those who have experienced a financial barrier between themselves and affordable treatment, the Part D Senior Savings Model may be extremely beneficial.

Let Avery Hall agents Alyssa Sinagra in Salisbury or Marti Wright in Easton find you a Medicare Part D Prescription plan participating in the Part D Senior Savings model during the upcoming Open Enrollment period, from October 15, 2020, through December 7, 2020. Call Alyssa at 410-742-5111 and Cynthia at 410-822-7300 today or request a quote online at

How Can Avery Hall Help You?
Thank you for your request! We'll be in touch soon.

Please enter your first name.

Please enter your last name.

Please enter your email address.

Please enter your phone number.

Please enter your city.

Please enter your state.

Please let us know what your question is.